Management of infections in neutropenic patients: New opportunities and emerging challenges

Current Opinion in Infectious Diseases

Volumn 7, Issue 4, 1994, Pages 430-435

  Karp, J E ^a   Merz, W G ^a   Dick, J D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBODY; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; COLONY STIMULATING FACTOR 1; CYTOKINE; DRUG VEHICLE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; ITRACONAZOLE; LIPID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

BACTERIAL INFECTION; CELLULAR IMMUNITY; CLINICAL TRIAL; ENTEROCOCCUS; HUMAN; HUMORAL IMMUNITY; INFECTION CONTROL; INTRANASAL DRUG ADMINISTRATION; MYCOSIS; NEUTROPENIA; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW;

EID: 0028015633     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199408000-00003     Document Type: Review

References (0)